Büşra Yılmaz TUĞAN, Levent KARABAŞ, Berna ÖZKAN

Toksoplazma Koryoretinitine Bağlı Geniş Seröz Makula Dekolmanı: Olgu Sunumu

Toxoplasma gondii koryoretinite sebep olabilen zorunlu intraselüler parazittir. Çoğunlukla kendine sınırlı bir hastalık olmasına rağmen optik sinir ya da maküla tutulumuna ve/veya ağır vitreus inflamasyonuna sekonder görme keskinliğini azaltabilir. Enfeksiyonun ‘klasik’ bulgusu pigmente koryoretinal skardır. Kenarında tüysü beyaz, nekrotizan retinokoroidit odağı görülebilir. Biz burada hızlı ve uygun bir tedavi sonucu anatomik ve fonksiyonel başarı elde ettiğimiz geniş seröz maküla dekolmanı ile komplike olmuş bir toksoplazma koyoretiniti olgusunu sunmayı amaçladık

Large Serous Macular Detachment Related To Toxoplasmic Chorioretinitis: a Case Report

Toxoplasma gondii is an obligate intracellular parasite, which can cause chorioretinitis. Although it is usually a selflimited disease, it may reduce vision secondary to the optic nerve or macular involvement and/or severe vitreous inflammation. The ‘classic’ sign of the infection is pigmented chorioretinal scar. The fluffy white nidus of the necrotizing retinochoroiditis can be seen adjacent to it. Here, we aimed to present a toxoplasmic chorioretinitis case complicated with a large serous macular detachment that we achieved anatomical and functional success as a result of prompt and suitable therapy

Keywords:

Serous macular detachment, toxoplasmic chorioretinitis, retinochoroiditis,

PDF

___

Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol 1973;57:1–17. [CrossRef]

Holland, GN., O’Connor, GR., Belfort, R., Junior; Remington, JS. Toxoplasmosis. In: Pepose, JS.; Holland, GN.; Wilhelmus, KR., editors. Ocular Infection & Immunity. St. Louis: Mosby; 1996. p. 1183-223.

Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol. 2002;134:102–14. [CrossRef]

Friedmann CT, Knox DL. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol. 1969; 81:481–93. [CrossRef]

Holland GN. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol. 2004;137:1–17.

Diniz B, Regatieri C, Andrade R, Maia A. Evaluation of spectral domain and time domain optical coherence tomography findings in toxoplasmic retinochoroiditis. Clin Ophthalmol 2011;5: 645–50. [CrossRef]

Foster CS, Vitale AT. Diagnosis and Treatment of Uveitis JP Medical Ltd. 2013

Ouyang Y, Li F, Shao Q, Heussen FM, Keane PA, Stübiger N, Sadda SR, Pleyer U. Subretinal fluid in eyes with active ocular toxoplasmosis observed using spectral domain optical coherence tomography. PLoS One 2015:26;10:e0127683. [CrossRef]

Lieb DF, Scott IU, Flynn HW Jr, Davis JL, Demming SM. Acute acquired toxoplasma retinitis may present similarly to unilateral acute idiopathic maculopathy. Am J Ophthalmol. 2004;137:940-2. [CrossRef]

Lieb DF, Scott IU, Flynn HW Jr, Davis JL, Demming SM. Acute Acquired Toxoplasma Retinitis May Present Similarly to Unilateral Acute Idiopathic Maculopathy . Am J Ophthalmol 2004;137:940–42. [CrossRef]

Engstrom RE, Holland GN, Nussenblatt RB, Jabs DA. Current Practices in the Management of Ocular Toxoplasmosis. Am J Ophthalmol. 1991;111:601–10. [CrossRef]

Rothova A, Bosch-Driessen LE, van Loon NH, Treffers WF. Azithromycin for ocular toxoplasmosis. Br J Ophthalmol. 1998;82:1306–8. [CrossRef]

Pearson PA, Piracha AR, Sen HA, Jaffe GJ. Atova-quone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. Ophthalmology. 1999;106:148–53. [CrossRef]